NCT04906070View on ClinicalTrials.gov

Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 25, 2019

Primary Completion Date

March 31, 2022

Study Completion Date

May 27, 2022

Conditions
Breast CancerHead and Neck Cancer
Interventions
DEVICE

HB-001

An intratumoral insertion of a seed(s), loaded with Radium-224, securely fixed in the seeds. The seeds release by recoil into the tumor short-lived alpha-emitting atoms.

Trial Locations (4)

980-8574

Tohoku University Hospital, Miyagi

573-1191

Kansai Medical University Hospital, Osaka

104-0045

National Cancer Center Hospital, Tokyo

113-8519

Tokyo Medical And Dental University Medical Hospital, Tokyo

Sponsors

Lead Sponsor

Hekabio
All Listed Sponsors
lead

Hekabio

INDUSTRY

NCT04906070 - Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan | Biotech Hunter | Biotech Hunter